The final goal: penicillin-binding proteins and the target of cephalosporins.
Fontana
R
R
Istituto di Microbiologia, Università degli Studi di Verona, Strada Le Grazie, 8, 37134 Verona, Italy.
Cornaglia
G
G
Ligozzi
M
M
Mazzariol
A
A
D001426:Bacterial Proteins; D002352:Carrier Proteins / Q000737:chemistry / Q000378:metabolism*; D002511:Cephalosporins / Q000378:metabolism* / Q000494:pharmacology* / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000201:enzymology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006095:Gram-Positive Cocci / Q000187:drug effects / Q000201:enzymology; D006602:Hexosyltransferases; D006801:Humans; D007700:Kinetics; D002267:Muramoylpentapeptide Carboxypeptidase / Q000737:chemistry / Q000378:metabolism*; D046915:Penicillin-Binding Proteins; D010458:Peptidyl Transferases; D013329:Structure-Activity Relationship
D001426:Bacterial Proteins; D002352:Carrier Proteins; D002511:Cephalosporins; D046915:Penicillin-Binding Proteins; D010458:Peptidyl Transferases; D006602:Hexosyltransferases; D002267:Muramoylpentapeptide Carboxypeptidase